Grand Pharmaceutical Group Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: BMG210A71016
HKD
8.18
-0.02 (-0.24%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Sino Biopharmaceutical Ltd.
China Medical System Holdings Ltd.
WuXi AppTec Co., Ltd.
Simcere Pharmaceutical Group Ltd.
Grand Pharmaceutical Group Ltd.
Sinopharm Group Co., Ltd.
China Resources Pharmaceutical Group Ltd.
Hygeia Healthcare Holdings Co., Ltd.
China Traditional Chinese Medicine Holdings Co. Ltd.
HUTCHMED (China) Ltd.
Akeso, Inc.
Why is Grand Pharmaceutical Group Ltd. ?
1
Negative results in Dec 24
  • INTEREST COVERAGE RATIO(Q) Lowest at 1,059.79
  • RAW MATERIAL COST(Y) Grown by 9.3% (YoY)
  • OPERATING PROFIT(Q) Lowest at HKD 997.49 MM
2
With ROE of 11.71%, it has a Expensive valuation with a 2.03 Price to Book Value
  • Over the past year, while the stock has generated a return of 75.16%, its profits have risen by 1.6% ; the PEG ratio of the company is 11
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Icon
No Data Found
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
13.34%
EBIT Growth (5y)
6.17%
EBIT to Interest (avg)
15.55
Debt to EBITDA (avg)
0.35
Net Debt to Equity (avg)
0.08
Sales to Capital Employed (avg)
0.53
Tax Ratio
14.29%
Dividend Payout Ratio
36.88%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
14.40%
ROE (avg)
14.09%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
17
Industry P/E
Price to Book Value
2.03
EV to EBIT
16.37
EV to EBITDA
13.22
EV to Capital Employed
1.95
EV to Sales
2.97
PEG Ratio
11.01
Dividend Yield
2.77%
ROCE (Latest)
11.93%
ROE (Latest)
11.71%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Icon
Not enough Data to analyse Financial Trend
Icon
Not enough Data to analyse Financial Trend
Here's what is working for Grand Pharmaceutical Group Ltd.
Cash and Eqv
Highest at HKD 3,140.94 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Depreciation
Highest at HKD 254.59 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (HKD MM)

Here's what is not working for Grand Pharmaceutical Group Ltd.
Interest Coverage Ratio
Lowest at 1,059.79
in the last five periods
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Operating Profit
Lowest at HKD 997.49 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (HKD MM)

Operating Profit Margin
Lowest at 17.82 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit
Lowest at HKD 707.47 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (HKD MM)

Net Profit
Lowest at HKD 756.55 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (HKD MM)

Raw Material Cost
Grown by 9.3% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales